Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.

MLA

Nutalai, Rungtiwa, et al. “Potent Cross-Reactive Antibodies Following Omicron Breakthrough in Vaccinees.” Cell, vol. 185, no. 12, June 2022, p. 2116. EBSCOhost, https://doi.org/10.1016/j.cell.2022.05.014.

APA

Nutalai, R., Zhou, D., Tuekprakhon, A., Ginn, H. M., Supasa, P., Liu, C., Huo, J., Mentzer, A. J., Duyvesteyn, H. M. E., Dijokaite-Guraliuc, A., Skelly, D., Ritter, T. G., Amini, A., Bibi, S., Adele, S., Johnson, S. A., Constantinides, B., Webster, H., Temperton, N., … Screaton, G. R. (2022). Potent cross-reactive antibodies following Omicron breakthrough in vaccinees. Cell, 185(12), 2116. https://doi.org/10.1016/j.cell.2022.05.014

Chicago

Nutalai, Rungtiwa, Daming Zhou, Aekkachai Tuekprakhon, Helen M Ginn, Piyada Supasa, Chang Liu, Jiandong Huo, et al. 2022. “Potent Cross-Reactive Antibodies Following Omicron Breakthrough in Vaccinees.” Cell 185 (12): 2116. doi:10.1016/j.cell.2022.05.014.